Rice Hall James & Associates’s Cantel Medical Corporation CMD Stock Holding History

Rice Hall James & Associates’s Portfolio CMD Stock Details CMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-2,826	Closed	-$223K	–	326
2020 Q4	$223K	Buy	+2,826	New	+$166K	0.01%	284
2014 Q4	–	Sell	-86,401	Closed	-$2.97M	–	320
2014 Q3	$2.97M	Sell	86,401 -1,139	-1%	-$40.2K	0.21%	123
2014 Q2	$3.21M	Sell	87,540 -700	-0.8%	-$23.7K	0.22%	105
2014 Q1	$2.98M	Sell	88,240 -2,628	-3%	-$86.7K	0.22%	127
2013 Q4	$3.08M	Sell	90,868 -4,400	-5%	-$152K	0.22%	129
2013 Q3	$3.03M	Sell	95,268 -302	-0.3%	-$8.03K	0.29%	106
2013 Q2	$2.16M	Buy	+95,570	New	+$2.07M	0.21%	142

Other funds holding CMD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

LGP

Leonard Green & Partners Los Angeles, California $2.77B AUM 3.28% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Diker Management New York $112M AUM 59.78% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

BCM

Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return

Rice Hall James & Associates's CMD Position: Q1 2021 in Review

Rice Hall James & Associates sold out of Cantel Medical Corporation (CMD) in Q1 2021, closing a stake of 2,826 shares — an estimated $223K sold.

Rice Hall James & Associates first reported a position in CMD in Q2 2013 and held it in 7 quarters. The position peaked at $3.21M in Q2 2014. 234 funds tracked by Wall St. Rank hold CMD as of Q1 2021.

Rice Hall James & Associates reported no remaining Cantel Medical Corporation position as of Q1 2021 after selling out during the quarter.
Rice Hall James & Associates sold 2,826 Cantel Medical Corporation shares in Q1 2021, an estimated $223K.
Rice Hall James & Associates first reported a position in Cantel Medical Corporation in Q2 2013 and held it in 7 quarters.
Rice Hall James & Associates's Cantel Medical Corporation position peaked at $3.21M in Q2 2014.
234 funds tracked by Wall St. Rank held Cantel Medical Corporation as of Q1 2021.

Based on Rice Hall James & Associates's 13F filing for Q1 2021, filed 14 May 2021.